Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 48819 [2016-17620]

Download as PDF Federal Register / Vol. 81, No. 143 / Tuesday, July 26, 2016 / Notices We estimate the burden for the preparation of each record to be .10 hours for a total burden of 2,400 hours. We estimate that all processors (15,000 processors) will maintain records of the calibration of processmonitoring instruments and the performing of any periodic end-product and in-process testing (§ 123.8(d)) at 47 records per processor for a total of 705,000 records. We estimate the burden for the preparation of each record to be .10 hours for a total burden of 70,500 hours. We estimate that all processors (15,000 processors) will maintain sanitation control records (§ 123.11(c)) at 280 records per processor for a total of 4,200,000 records. We estimate the burden for the preparation of each record to be .10 hours for a total burden of 420,000 hours. We estimate that all importers (4,100 importers) will maintain records that verify that the fish and fishery products they offer for import into the United States were processed in accordance with the HACCP and sanitation provisions set forth in part 123 (§ 123.12(c)). We estimate that 80 records will be prepared per importer for a total of 328,000 records. We estimate the burden for the preparation of each record to be .10 hours for a total burden of 32,800 hours. We estimate that 1 percent of all importers (41 importers) will require new written verification procedures to verify compliance of imports (§ 123.12(a)(2)). We estimate the burden for preparing the new procedures to be 4 hours per importer for a total burden of 164 hours. Dated: July 19, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016–17571 Filed 7–25–16; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Meeting of the Presidential Commission for the Study of Bioethical Issues Presidential Commission for the Study of Bioethical Issues, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice of meeting. srobinson on DSK5SPTVN1PROD with NOTICES AGENCY: The Presidential Commission for the Study of Bioethical Issues (the Commission) will conduct its twentysixth meeting on August 31, 2016. At this meeting, the Commission will SUMMARY: VerDate Sep<11>2014 20:28 Jul 25, 2016 Jkt 238001 reflect on the past, present, and future impact of national bioethics advisory bodies. Topics will include the history of national bioethics advisory bodies and their contributions to health policy, perspectives about similar bodies elsewhere, and discussion about what the future holds for groups like the Commission. DATES: The meeting will take place August 31, 2016, from 9 a.m. to approximately 4 p.m. ADDRESSES: Annenberg Public Policy Center, 202 S. 36th St., Philadelphia, PA 19104. FOR FURTHER INFORMATION CONTACT: Lisa M. Lee, Executive Director, Presidential Commission for the Study of Bioethical Issues, 330 C Street SW., Suite L001, Washington, DC 20201. Telephone: 202–795–7689. Email: Lisa.Lee@ bioethics.gov. Additional information may be obtained at www.bioethics.gov. SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee Act of 1972, Public Law 92–463, 5 U.S.C. app. 2, notice is hereby given of the twenty-sixth meeting of the Commission. The meeting will be open to the public with attendance limited to space available. The meeting will also be webcast at www.bioethics.gov. Under authority of Executive Order 13521, dated November 24, 2009, the President established the Commission. The Commission is an expert panel of not more than 13 members who are drawn from the fields of bioethics, science, medicine, technology, engineering, law, philosophy, theology, or other areas of the humanities or social sciences. The Commission advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. The Commission seeks to identify and promote policies and practices that ensure scientific research, health care delivery, and technological innovation are conducted in a socially and ethically responsible manner. The main agenda for the Commission’s twenty-sixth meeting is to reflect upon the role of national bioethics advisory bodies, both in the US and abroad, in the past, present, and future. The Commission welcomes input from anyone wishing to provide public comment on any issue before it. Respectful consideration of opposing views and active participation by citizens in public exchange of ideas enhances overall public understanding of the issues at hand and conclusions reached by the Commission. The Commission is particularly interested in receiving comments and questions PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 48819 during the meeting that are responsive to specific sessions. Written comments will be accepted in advance, during, and after the meeting and are especially welcome. Comments will be publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted. Written comments will be accepted by email to info@bioethics.gov, or by mail to the following address: Public Commentary, Presidential Commission for the Study of Bioethical Issues, 330 C Street SW., Suite L001, Washington, DC 20201. To accommodate as many individuals as possible, the time for each question or comment may be limited. If the number of individuals wishing to pose a question or make a comment is greater than can reasonably be accommodated during the scheduled meeting, the Commission may make a random selection. Time permitting, we will read aloud as many comments as possible. Anyone planning to attend the meeting who needs special assistance, such as sign language interpretation or other reasonable accommodations, should notify Esther Yoo by telephone at (202) 795–7689, or email at Esther.Yoo@bioethics.gov at least one week in advance of the meeting. The Commission will make every effort to accommodate persons who need special assistance. Dated: July 8, 2016. Lisa M. Lee, Executive Director, Presidential Commission for the Study of Bioethical Issues. [FR Doc. 2016–17620 Filed 7–25–16; 8:45 am] BILLING CODE 4154–06–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which E:\FR\FM\26JYN1.SGM 26JYN1

Agencies

[Federal Register Volume 81, Number 143 (Tuesday, July 26, 2016)]
[Notices]
[Page 48819]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-17620]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the Presidential Commission for the Study of 
Bioethical Issues

AGENCY: Presidential Commission for the Study of Bioethical Issues, 
Office of the Assistant Secretary for Health, Office of the Secretary, 
Department of Health and Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Presidential Commission for the Study of Bioethical Issues 
(the Commission) will conduct its twenty-sixth meeting on August 31, 
2016. At this meeting, the Commission will reflect on the past, 
present, and future impact of national bioethics advisory bodies. 
Topics will include the history of national bioethics advisory bodies 
and their contributions to health policy, perspectives about similar 
bodies elsewhere, and discussion about what the future holds for groups 
like the Commission.

DATES: The meeting will take place August 31, 2016, from 9 a.m. to 
approximately 4 p.m.

ADDRESSES: Annenberg Public Policy Center, 202 S. 36th St., 
Philadelphia, PA 19104.

FOR FURTHER INFORMATION CONTACT: Lisa M. Lee, Executive Director, 
Presidential Commission for the Study of Bioethical Issues, 330 C 
Street SW., Suite L001, Washington, DC 20201. Telephone: 202-795-7689. 
Email: Lisa.Lee@bioethics.gov. Additional information may be obtained 
at www.bioethics.gov.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given 
of the twenty-sixth meeting of the Commission. The meeting will be open 
to the public with attendance limited to space available. The meeting 
will also be webcast at www.bioethics.gov.
    Under authority of Executive Order 13521, dated November 24, 2009, 
the President established the Commission. The Commission is an expert 
panel of not more than 13 members who are drawn from the fields of 
bioethics, science, medicine, technology, engineering, law, philosophy, 
theology, or other areas of the humanities or social sciences. The 
Commission advises the President on bioethical issues arising from 
advances in biomedicine and related areas of science and technology. 
The Commission seeks to identify and promote policies and practices 
that ensure scientific research, health care delivery, and 
technological innovation are conducted in a socially and ethically 
responsible manner.
    The main agenda for the Commission's twenty-sixth meeting is to 
reflect upon the role of national bioethics advisory bodies, both in 
the US and abroad, in the past, present, and future.
    The Commission welcomes input from anyone wishing to provide public 
comment on any issue before it. Respectful consideration of opposing 
views and active participation by citizens in public exchange of ideas 
enhances overall public understanding of the issues at hand and 
conclusions reached by the Commission. The Commission is particularly 
interested in receiving comments and questions during the meeting that 
are responsive to specific sessions. Written comments will be accepted 
in advance, during, and after the meeting and are especially welcome. 
Comments will be publicly available, including any personally 
identifiable or confidential business information that they contain. 
Trade secrets should not be submitted.
    Written comments will be accepted by email to info@bioethics.gov, 
or by mail to the following address: Public Commentary, Presidential 
Commission for the Study of Bioethical Issues, 330 C Street SW., Suite 
L001, Washington, DC 20201. To accommodate as many individuals as 
possible, the time for each question or comment may be limited. If the 
number of individuals wishing to pose a question or make a comment is 
greater than can reasonably be accommodated during the scheduled 
meeting, the Commission may make a random selection. Time permitting, 
we will read aloud as many comments as possible.
    Anyone planning to attend the meeting who needs special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify Esther Yoo by telephone at (202) 795-
7689, or email at Esther.Yoo@bioethics.gov at least one week in advance 
of the meeting. The Commission will make every effort to accommodate 
persons who need special assistance.

    Dated: July 8, 2016.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical 
Issues.
[FR Doc. 2016-17620 Filed 7-25-16; 8:45 am]
 BILLING CODE 4154-06-P